Crossmark

Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity

Crossref DOI link: https://doi.org/10.1038/s41596-018-0076-8

Published Online: 2018-11-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Arun http://orcid.org/0000-0002-0607-5455
McKeithan, Wesley L. http://orcid.org/0000-0003-4413-6068
Serrano, Ricardo

Kitani, Tomoya

Burridge, Paul W.

del Álamo, Juan C.

Mercola, Mark

Wu, Joseph C.
License Information

Text and Data Mining valid from 2018-11-09
More Information

Article History

First Online: 9 November 2018

Competing interests

: M.M. holds equity in and is on the scientific advisory board for Vala Sciences, a company offering high-content screening services and instrumentation for measuring the electrical and contractile physiology of CMs. J.C.W. is a cofounder of and scientific advisory board member for Khoris, a company using hiPSCs to accelerate drug discovery. The remaining authors declare no competing interests.